- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03118167
Intervention Effect of TP and AOB-w on Acrylamide Exposure in Chinese Adolescents
May 16, 2017 updated by: Yu Zhang, Zhejiang University
Intervention Effect of Tea Polyphenols (TP) and Water-Soluble Antioxidant Of Bamboo Leaves (AOB-w) on Short- and Long-term Internal Exposure of Acrylamide in Chinese Adolescents
A double-blind randomized controlled trial (RCT) was conducted in current human study.
This study aims to investigate the intervention effect of AOB-w on the short-term exposure and toxicokinetics of acrylamide, a dietary hazardous substance generated during heat processing, in Chinese adolescents.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In the morning of test day, participants were served with a meal of potato chips, corresponding to a single oral dose of 12.6 μg/kg b.w.
exposure to acrylamide, and an edible capsule, which contains 350 mg AOB-w or the placebo with the same dose.
Urine were collected within 48 hours thereafter.
The diet was rigorously controlled within 24 hours prior to study till entire study finished.
Four mercapturic acid metabolites have been investigated as urinary biomarkers for short-term internal exposure of acrylamide in human
Study Type
Interventional
Enrollment (Actual)
110
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years to 29 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject has no smoking or drinking hobby
Exclusion Criteria:
- Having any drugs within 7days
- Smoking or drinking
- Pregnant, trying to become pregnant or breast feeding
- Allergic frying foods
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tea polyphenols & Acrylamide
TP 0.05g, 0.1g, 0.2g (starches filled, up to 0.35g) capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
|
Tea polyphenols 0.05g, 0.1g, 0.2g (starches filled up to 0.35g), edible capsule
Other Names:
Potato Chips bought from market, corresponding to acrylamide (12.6μg/kg b.w. )
|
|
Experimental: AOB-w & Acrylamide
AOB-w 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
|
Potato Chips bought from market, corresponding to acrylamide (12.6μg/kg b.w. )
Water-soluble antioxidant of bamboo leaves 0.35g, edible capsule
Other Names:
|
|
Active Comparator: Placebo & Acrylamide
Placebo (Starches) 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
|
Potato Chips bought from market, corresponding to acrylamide (12.6μg/kg b.w. )
Edible starches 0.35g, edible capsule
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of four urinary biomarkers of acrylamide
Time Frame: up to 48 hours
|
Urine was collected prior to the potato chips meal and 48 hours thereafter, up to 10 urine samples for each participants.
Urinary biomarkers of acrylamide were detected by UHPLC-MS/MS.
|
up to 48 hours
|
|
Change of two hemoglobin adducts of acrylamide
Time Frame: baseline, 3 and 10 days
|
Blood samples were collected in 0, 3, 10days after the intake of potato chips meals.
Two hemoglobin adducts (AAVal and GAVal) of acrylamide were detected by UHPLC-MS/MS.
|
baseline, 3 and 10 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Area under the concentration versus time curve (AUC) Of acrylamide urinary biomarkers
Time Frame: baseline, 2, 4, 6, 8, 10, 14, 24, 36 and 48 hours
|
Dynamic changes of biomarkers during the specified intervention period, following 10 urine samples in 48 hours thereafter.
|
baseline, 2, 4, 6, 8, 10, 14, 24, 36 and 48 hours
|
|
Maximum Concentration (Cmax) of Acrylamide Urinary Biomarkers
Time Frame: 48 hours
|
Maximum concentration of urinary biomarkers during the specified period, measured by curve fitting tools of Matlab Software.
|
48 hours
|
|
Time to Peak Concentration (tmax) of Acrylamide Urinary Biomarkers
Time Frame: 48 hours
|
Time to Peak Concentration (tmax) of Acrylamide Urinary Biomarkers during the specified period, measured by curve fitting tools of Matlab Software.
|
48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
November 24, 2016
First Submitted That Met QC Criteria
April 14, 2017
First Posted (Actual)
April 18, 2017
Study Record Updates
Last Update Posted (Actual)
May 17, 2017
Last Update Submitted That Met QC Criteria
May 16, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RCT-001-AA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intervention
-
University of HaifaCompletedPsychological Intervention | Internet-Based Intervention | Intervention StudyIsrael
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingMusic Listening Intervention | Mindfulness-based InterventionCanada
-
Research Foundation for Mental Hygiene, Inc.CompletedBrief Video-based Intervention | Vignette Based Intervention | Non Intervention Control ArmUnited States
-
Children's Hospital of Fudan UniversityCompleted
-
Matrouh UniversityCompleted
-
Northwestern UniversityNational Institute of Mental Health (NIMH)Recruiting
-
Leeds Beckett UniversityCompleted
-
University of ExeterRecruitingNutritional InterventionUnited Kingdom
-
University of Missouri-ColumbiaRecruitingDiet InterventionUnited States
-
City University of Hong KongThe University of Hong Kong; Education University of Hong Kong; Tung Wah Group... and other collaboratorsEnrolling by invitationParenting InterventionHong Kong
Clinical Trials on Tea polyphenols
-
Texas Tech University Health Sciences CenterNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Xuanwu Hospital, BeijingMinistry of Health, China; Michael J. Fox Foundation for Parkinson's ResearchCompletedParkinson's DiseaseChina
-
Sinphar Pharmaceutical Co., LtdCompleted
-
Technical University of MunichCompletedHeart Failure | Inflammation | Sudden Cardiac DeathGermany
-
University Hospital, Strasbourg, FranceTerminated
-
University of ReadingUnited States Department of DefenseCompletedStress, Psychological | Gut BacteriaUnited Kingdom
-
University of California, Los AngelesCompletedType II Diabetes MellitusUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
King's College LondonDIANA FoodCompletedPrevention of HyperglycaemiaUnited Kingdom
-
Northumbria UniversityThe New Zealand Institute for Plant and Food ResearchCompleted